Huahaipharm: Two products have obtained drug registration certificates
I'm PortAI, I can summarize articles.
Huahaipharm recently obtained two drug registration certificates approved by the National Medical Products Administration, including Candesartan Cilexetil and Hydrochlorothiazide Tablets (II) and Injection of Rosuvastatin Acetate. The approval for the production of these two products can be regarded as passing the consistency evaluation, further enriching the company's product line, enhancing market competitiveness, and having a positive impact on the company's operational development
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments